1. 3310 LOGIC2: Phase 2, multi-center, open-label study of sequential encorafenib/binimetinib combination followed by a rational combination with targeted agents after progression, to overcome resistance in adult patients with locally-advanced or metastatic BRAF V600 melanoma. (September 2015) Authors: Dummer, R.; Sandhu, S.; Hassel, J.C.; Muñoz, E.; Berking, C.; Gesierich, A.; Ascierto, P.A.; Esposito, O.; Carter, K.; Antona, V.; Radhakrishnan, R.; Cui, X.; Caponigro, G.; Jaeger, S.; Demuth, T.; Miller Jr, W.H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. (1st February 2018) Authors: Teramoto, Y.; Keim, U.; Gesierich, A.; Schuler, G.; Fiedler, E.; Tüting, T.; Ulrich, C.; Wollina, U.; Hassel, J.C.; Gutzmer, R.; Goerdt, S.; Zouboulis, C.; Leiter, U.; Eigentler, T.K.; Garbe, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. (20th December 2017) Authors: Teramoto, Y.; Keim, U.; Gesierich, A.; Schuler, G.; Fiedler, E.; Tüting, T.; Ulrich, C.; Wollina, U.; Hassel, J.C.; Gutzmer, R.; Goerdt, S.; Zouboulis, C.; Leiter, U.; Eigentler, T.K.; Garbe, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. (1st September 2020) Authors: Weber, J.; Glutsch, V.; Geissinger, E.; Haug, L.; Lock, J.F.; Schneider, F.; Kneitz, H.; Goebeler, M.; Schilling, B.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nocardiosis in a patient with anti-PD-1–associated colitis treated with infliximab. (September 2018) Authors: Glutsch, V.; Gesierich, A.; Goebeler, M.; Forster, J.; Schilling, B. Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pembrolizumab‐associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma. (1st October 2018) Authors: Haug, V.; Behle, V.; Benoit, S.; Kneitz, H.; Schilling, B.; Goebeler, M.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗